CME Outfitters Announces Live psychCME TV Activity: "Schizophrenia and Bipolar Disorder: The Convergence of Medication Strategies" Premieres Wednesday, July 6, 2005

CME Outfitters, LLC, nationally accredited provider of multidisciplinary medical education programming and related healthcare communications services, is pleased to announce an upcoming live and interactive CE activity titled "Schizophrenia and Bipolar Disorder: The Convergence of Medication Strategies." Offered as a live satellite broadcast, webcast, and telephone audioconference premiering Wednesday, July 6, 2005, from 12:00 p.m.–1:00 p.m. ET, the activity will focus on providing current and clinically relevant educational information regarding the convergence of pharmacologic agents in the treatment of both schizophrenia and bipolar disorder.

Rockville, MD (PRWEB) June 7, 2005 -- CME Outfitters, LLC, nationally accredited provider of multidisciplinary medical education programming and related healthcare communications services, is pleased to announce an upcoming live and interactive CE activity titled "Schizophrenia and Bipolar Disorder: The Convergence of Medication Strategies." Offered as a live satellite broadcast, webcast, and telephone audioconference premiering Wednesday, July 6, 2005, from 12:00 p.m.–1:00 p.m. ET, the activity will focus on providing current and clinically relevant educational information regarding the convergence of pharmacologic agents in the treatment of both schizophrenia and bipolar disorder. The recorded satellite broadcast will re-air from 3:00 p.m.–4:00 p.m. ET. This CE activity will be available as an archived webcast and telephone audioconference shortly after the live broadcast, and available as a videotape or multimedia CD-ROM in August.

Participation in this activity is free, as is obtaining a CE certificate; however, registration is required. Three forms of registration are accepted:
Fax: View the activity details page at http://www.psychCME.net/cmea.asp?ID=115, print and complete the activity details form, and fax to 240.243.1033
Online: Visit the psychCME TV page at http://www.psychCME.net
Phone: Call 877.CME.PROS (877.263.7767)

Statement of Need:
Second-generation antipsychotics (SGA) produce fewer extrapyramidal side effects, a lower rate of tardive dyskinesia, and have a broader spectrum of efficacy compared with first-generation antipsychotics. Because of this superior profile, SGAs have more or less replaced first-generation antipsychotics for the treatment of schizophrenia. In addition, multiple clinical trials have now demonstrated the efficacy of SGAs in bipolar mania and bipolar maintenance. With the recognition that SGAs are useful in the treatment of both schizophrenia and bipolar mania and that combining them with classic mood stabilizers such as valproate may result in increased efficacy, the field of psychiatry is witnessing a convergence of pharmacologic approaches to the treatment of schizophrenia and bipolar disorder. Until the precise pathophysiology of psychotic disorders can be elucidated, clinicians are likely to continue using blended treatments for both schizophrenia and bipolar disorder. In this evidence-based psychCME TV activity, the faculty will explore the current evidence for the use of SGAs in these two psychiatric disorders.

psychCME Chair and Moderator:
Prakash S. Masand, MD
Consulting Professor of Psychiatry
Duke University Medical Center
Durham, NC

Faculty:
Peter F. Buckley, MD
Professor and Chairman
Department of Psychiatry and Health Behavior
Medical College of Georgia
Augusta, GA

Roger S. McIntyre, MD, FRCPC
Assistant Professor of Psychiatry
Head, Mood Disorders and Psychopharmacology Unit
University of Toronto

Activity Goal:
To provide current and clinically relevant educational information regarding the convergence of pharmacologic agents in the treatment of both schizophrenia and bipolar disorder.

Learning Objectives:
At the end of this CE activity, participants should be able to:
- Assess the varying strengths of the current evidence supporting combination strategies with SGAs in schizophrenia and bipolar disorder.
- Utilize clinical judgment to assess the efficacy of converging pharmacologic strategies in patients with schizophrenia and bipolar disorder.
- Identify the role of psychotherapeutic strategies in the treatment of schizophrenia and bipolar disorder.

Target Audience:
Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals with an interest in mental health.

Commercial Support:
CME Outfitters, LLC, gratefully acknowledges an educational grant from Pfizer Inc. in support of this CE activity.

Credit Information:
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

CNE Credit (Nurses):
This Educational Activity is presented by CME Outfitters, LLC, which has been approved as a provider of continuing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. It has been assigned code 5UYSJZ-PRV-0459. 1.2 contact hours (Pharmacology)

CEP Credit (Psychologists):
CME Outfitters, LLC, is approved by the American Psychological Association to offer continuing education for psychologists. CME Outfitters, LLC, maintains responsibility for the program. 1.0 CE credits

NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.

CCMC Credit (Certified Case Managers):
This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Program Number:
376-999-05-014-L01 (live presentation)
376-999-05-014-H01 (recorded programs)

To receive credit, participants must review all activity materials in their entirety, score 70% or above on a post-test, and fully complete and return both the credit request form and activity evaluation. A certificate or statement of credit will be mailed within 4–6 weeks to all who successfully complete these requirements.

About CME Outfitters:
CME Outfitters is a full service healthcare communications agency providing continuing education content development, production, marketing, accreditation, and project management services to the healthcare industry. Among its many collaborative ventures, CME Outfitters enjoys an exclusive role in producing, certifying, and supporting the popular psychCME series of educational activities originally developed at Duke University Medical Center. For more information on CME Outfitters, including a complete calendar of its free award-winning educational activities, please visit http://www.cmeoutfitters.com, or call 877.CME.PROS (877.263.7767).

To view all of CME Outfitters' recent press releases, visit http://www.cmeoutfitters.com and click on "CME Outfitters in the News" or visit http://www.prweb.com and search for "CME Outfitters."

CME Outfitters' weekly e-newsletter, psychCME EXTRA, is a convenient way to stay informed of all CME Outfitters news and information. To subscribe, visit http://www.cmeoutfitters.com and click on "Register for Updates."

Contact: Christopher Perez
CME Outfitters, LLC
240.243.1303 direct
240.243.1033 fax

# # #

Source :  http://www.prweb.com/releases/2005/6/prweb248359.htm